Buy CARBOPLATIN INJECTION 10 MG CARBOPLATIN

Carboplatin Injection 10 MG is a liquid intravenous medication used for various therapeutic purposes. This product by Teva Canada Limited is available in 5ML, 15ML, and 45ML vials.

Strength

10 MG

Pack Size

5ML,15ML & 45ML VIALS

Manufacturer / TM Owner

TEVA CANADA LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Carboplatin Injection 10 MG is commonly used in medical settings for its cytotoxic properties. It is often administered intravenously to target rapidly dividing cells, making it a key component in certain treatment protocols. Patients and healthcare providers may explore carboplatin 10 mg uses for conditions requiring such interventions.

Side Effects

When administered, Carboplatin Injection 10 MG may cause various effects, including nausea, vomiting, and fatigue. Some individuals might experience changes in blood cell counts or hair loss. These effects can vary widely among patients, and it's important to monitor for any adverse reactions.

Precautions & Warnings

Handling Carboplatin Injection 10 MG requires careful attention to safety protocols. It should only be administered by healthcare professionals in a controlled environment. Patients should be monitored for any signs of allergic reactions or other severe side effects. Proper disposal of used vials is essential to prevent environmental contamination.

Avoid Interactions

Carboplatin Injection 10 MG may interact with other medications, including those that affect the bone marrow or immune system. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain supplements might also influence the effectiveness or safety of carboplatin.

References

Frequently Asked Questions

Carboplatin Injection 10 MG is used in medical settings for its cytotoxic properties, often targeting rapidly dividing cells.

Carboplatin Injection 10 MG is administered intravenously by healthcare professionals in a controlled environment.

Common side effects may include nausea, vomiting, fatigue, and changes in blood cell counts.

It is important to consult healthcare providers about potential interactions with other medications before using Carboplatin Injection 10 MG.

Precautions include administering in a controlled environment, monitoring for allergic reactions, and proper disposal of used vials.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.